- Home
- PDD vs PFE Comparison
PDD vs PFE Comparison
Compare PDD & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PDD | PFE |
|---|---|---|
| Founded | 2015 | 1849 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.5B | 147.6B |
| IPO Year | 2018 | 2013 |
Fundamental Metrics
Financial Performance| Metric | PDD | PFE |
|---|---|---|
| Price | $83.78 | $24.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | ★ $139.22 | $29.29 |
| AVG Volume (30 Days) | 7.5M | ★ 38.4M |
| Earning Date | 05-26-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.55% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.47 |
| Revenue | N/A | ★ $62,579,000,000.00 |
| Revenue This Year | $15.35 | N/A |
| Revenue Next Year | $12.63 | N/A |
| P/E Ratio | ★ $10.63 | $52.18 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $71.94 | $23.11 |
| 52 Week High | $139.41 | $28.75 |
Technical Indicators
Market Signals| Indicator | PDD | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 51.28 | 42.83 |
| Support Level | $81.56 | $23.96 |
| Resistance Level | $107.53 | $24.77 |
| Average True Range (ATR) | 2.54 | 0.52 |
| MACD | 1.19 | 0.06 |
| Stochastic Oscillator | 76.49 | 40.27 |
Price Performance
Historical ComparisonAbout PDD PDD Holdings Inc.
PDD Holdings operates commerce businesses in over 80 countries globally. Its main operations are Pinduoduo, a social commerce platform in China, and Temu, a global e-commerce marketplace. PDD also has a community group purchase business in China. PDD has built a network of sourcing, logistics, and fulfillment capabilities that support its underlying businesses.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.